Patents Assigned to CARDIORISK LLC
  • TROPONIN I AND SOLUBLE UROKINASE RECEPTOR DETECTION FOR DETERMINING THE RISK OF CARDIOVASCULAR DISEASE
    Publication number: 20190025328
    Abstract: Disclosed are systems and methods for detecting the sample concentration of cardiac troponin I (cTnI) and the sample concentration of soluble urokinase receptor (suPAR) to determine if a subject has or is at risk for developing cardiovascular disease or a complication of previously diagnosed cardiovascular disease.
    Type: Application
    Filed: October 27, 2016
    Publication date: January 24, 2019
    Applicants: ABBOTT LABORATORIES, EMORY UNIVERSITY, CARDIORISK LLC
    Inventors: Agim Beshiri, Arshed Ali Quyyumi, Sergey Sikora, Stephen Epstein